E2F1 and breast cancer: It has been reported that proliferating cell nuclear antigen (PCNA) enhancement, in addition to p53 and p21 suppression, leads to the activation of E2F1 and relief of inhibition of PCNA, enabling regulation of the cell cycle in breast cancer cells [29].